OCT Announces 2nd Clinical Trial, Chill Brands Investor Calls For Director Ousting, & More From SEED
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies (OCT) has announced plans to launch a Phase 1 clinical trial into a
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies (OCT) has announced plans to launch a Phase 1 clinical trial into a
Chill Brands Chill Brands has seen its stock price drop by more than 30% this week following news that
Chill Brands Chill Brands published a ‘trading update’ to investors this morning, revealing growth in a number of key
 Celadon Pharmaceuticals This morning (November 16), AIM-listed medical cannabis operator Celadon Pharmaceuticals announced that it has signed a
Northern Leaf Jersey-based medical cannabis cultivator Northern Leaf have said they are ‘very confident’ of launching an AIM listing in
Celadon Pharmaceuticals LSE-listed Celadon Pharmaceuticals announced that it had signed a new commercial sales contract set to be worth
MGC Pharmaceuticals MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m
Chill Brands Group Chill Brands’ stock value has nearly doubled over the last week following the announcement of a
InterCure InterCure has continued its blistering run of financial performance after revealing another record quarter over the weekend, ‘solidifying
WHILE last week’s news from the US saw many EU cannabis stocks experience a spike in stock price on Friday,
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.